Time for a Time Window Extension: Insights from Late Presenters in the ESCAPE Trial

BACKGROUND AND PURPOSE: The safety and efficacy of endovascular therapy for large-artery stroke in the extended time window is not yet well-established. We performed a subgroup analysis on subjects enrolled within an extended time window in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) trial. MATERIALS AND METHODS: Fifty-nine of 315 subjects (33 in the intervention group and 26 in the control group) were randomized in the ESCAPE trial between 5.5 and 12 hours after last seen healthy (likely to have groin puncture administered 6 hours after that). Treatment effect sizes for all relevant outcomes (90-day mRS shift, mRS 0–2, mRS 0–1, and 24-hour NIHSS scores and intracerebral hemorrhage) were reported using unadjusted and adjusted analyses. RESULTS: There was no evidence of treatment heterogeneity between subjects in the early and late windows. Treatment effect favoring intervention was seen across all clinical outcomes in the extended time window (absolute risk difference of 19.3% for mRS 0–2 at 90 days). There were more asymptomatic intracerebral hemorrhage events within the intervention arm (48.5% versus 11.5%, P = .004) but no difference in symptomatic intracerebral hemorrhage. CONCLUSIONS: Patients with an extended time window could potentially benefit from endovascular treatment. Ongoing randomized controlled trials using imaging to identify late presenters with favorable brain physiology will help cement the paradigm of using time windows to select the population for acute imaging and imaging to select individual patients for therapy.

[1]  E. Lindsay Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct , 2018 .

[2]  Adnan H Siddiqui,et al.  Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. , 2016, JAMA.

[3]  A. Demchuk,et al.  Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials , 2016, The Lancet.

[4]  A. Demchuk,et al.  Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial , 2016, Circulation.

[5]  Eric E. Smith,et al.  Canadian Stroke Best Practice Recommendations: Acute Inpatient Stroke Care Guidelines, Update 2015 , 2016, International journal of stroke : official journal of the International Stroke Society.

[6]  C. Gerloff,et al.  Treatment Concepts for Wake-Up Stroke and Stroke With Unknown Time of Symptom Onset , 2015, Stroke.

[7]  A. Demchuk,et al.  Ischemic Stroke Tissue-Window in the New Era of Endovascular Treatment. , 2015, Stroke.

[8]  Christopher S Coffey,et al.  2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.

[9]  A. Demchuk,et al.  Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial , 2015, Stroke.

[10]  A. Demchuk,et al.  Endovascular Treatment for Small Core and Anterior Circulation Proximal Occlusion with Emphasis on Minimizing CT to Recanalization Times (ESCAPE) Trial: Methodology , 2015, International journal of stroke : official journal of the International Stroke Society.

[11]  Eric E. Smith,et al.  Randomized assessment of rapid endovascular treatment of ischemic stroke. , 2015, The New England journal of medicine.

[12]  D. Liebeskind,et al.  Impact of Time-to-Reperfusion on Outcome in Patients with Poor Collaterals , 2015, American Journal of Neuroradiology.

[13]  A. Demchuk,et al.  Stroke- on- Awakening: Safety of CT-CTA Based Selection for Reperfusion Therapy , 2014, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[14]  A. Demchuk,et al.  Tissue Window in Stroke Thrombolysis Study (TWIST): A Safety Study , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[15]  F. Silver,et al.  Outcome after Stroke upon Awakening , 2005, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[16]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.